MX373056B - Formas cristalinas de glecaprevir. - Google Patents

Formas cristalinas de glecaprevir.

Info

Publication number
MX373056B
MX373056B MX2016016127A MX2016016127A MX373056B MX 373056 B MX373056 B MX 373056B MX 2016016127 A MX2016016127 A MX 2016016127A MX 2016016127 A MX2016016127 A MX 2016016127A MX 373056 B MX373056 B MX 373056B
Authority
MX
Mexico
Prior art keywords
crystalline forms
glecaprevir
compound
crystalline
figures
Prior art date
Application number
MX2016016127A
Other languages
English (en)
Spanish (es)
Other versions
MX2016016127A (es
Inventor
Ahmad Y Sheikh
Bradley D Gates
Shuang Chen
Original Assignee
Abbvie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Inc filed Critical Abbvie Inc
Publication of MX2016016127A publication Critical patent/MX2016016127A/es
Publication of MX373056B publication Critical patent/MX373056B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0827Tripeptides containing heteroatoms different from O, S, or N
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
MX2016016127A 2014-06-06 2015-06-05 Formas cristalinas de glecaprevir. MX373056B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462008786P 2014-06-06 2014-06-06
PCT/US2015/034371 WO2015188045A1 (en) 2014-06-06 2015-06-05 Crystal forms

Publications (2)

Publication Number Publication Date
MX2016016127A MX2016016127A (es) 2017-02-23
MX373056B true MX373056B (es) 2020-05-20

Family

ID=54767417

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016016127A MX373056B (es) 2014-06-06 2015-06-05 Formas cristalinas de glecaprevir.

Country Status (8)

Country Link
US (2) US9321807B2 (https=)
EP (2) EP3151850A4 (https=)
JP (4) JP2017518319A (https=)
CN (1) CN106413736A (https=)
AU (2) AU2015269306B2 (https=)
CA (1) CA2948902C (https=)
MX (1) MX373056B (https=)
WO (1) WO2015188045A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3151850A4 (en) * 2014-06-06 2017-11-29 AbbVie Inc. Crystal forms
WO2021137256A1 (en) 2020-01-03 2021-07-08 Mylan Laboratories Limited Polymorphic forms of glecaprevir
GB202113944D0 (en) * 2021-09-29 2021-11-10 Univ Liverpool Injectable formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604234A (en) * 1991-09-05 1997-02-18 Abbott Laboratories Substituted thiol macrolactam immunomodulators
UY28240A1 (es) * 2003-03-27 2004-11-08 Boehringer Ingelheim Pharma Fases cristalinas de un potente inhibidor de la hcv
KR100995390B1 (ko) * 2006-01-02 2010-11-19 주식회사 삼양제넥스 무정형, 무수결정형 또는 수화 결정형 도세탁셀의 제조방법
EA019327B1 (ru) 2008-07-22 2014-02-28 Мерк Шарп Энд Домэ Корп. Макроциклическое хиноксалиновое соединение в качестве ингибитора протеазы вгс ns3
EP2470189A4 (en) * 2009-08-27 2013-01-23 Merck Sharp & Dohme METHOD FOR PRODUCING PROTEASE INHIBITORS OF HEPATITIS C VIRUS
SG188618A1 (en) * 2010-09-21 2013-04-30 Enanta Pharm Inc Macrocyclic proline derived hcv serine protease inhibitors
EP2744331A4 (en) * 2011-08-19 2015-01-21 Merck Sharp & Dohme METHOD AND INTERMEDIATE PRODUCTS FOR THE MANUFACTURE OF MACROLACTAMEN
NZ630435A (en) * 2012-07-12 2016-11-25 Abbvie Inc Crystalline forms of an hcv inhibitor
US20150119400A1 (en) * 2013-10-25 2015-04-30 Abbvie, Inc. Methods for treating hcv
EP3151850A4 (en) * 2014-06-06 2017-11-29 AbbVie Inc. Crystal forms

Also Published As

Publication number Publication date
JP2025004239A (ja) 2025-01-14
JP2021113192A (ja) 2021-08-05
US9321807B2 (en) 2016-04-26
CA2948902A1 (en) 2015-12-10
EP3151850A4 (en) 2017-11-29
AU2015269306A1 (en) 2016-12-22
US20150353600A1 (en) 2015-12-10
EP3151850A1 (en) 2017-04-12
US9561181B2 (en) 2017-02-07
WO2015188045A1 (en) 2015-12-10
CA2948902C (en) 2022-11-22
AU2015269306B2 (en) 2020-06-25
AU2020239679A1 (en) 2020-10-15
EP4403223A2 (en) 2024-07-24
JP2023089125A (ja) 2023-06-27
EP4403223A3 (en) 2024-10-09
JP2017518319A (ja) 2017-07-06
US20160220487A1 (en) 2016-08-04
MX2016016127A (es) 2017-02-23
CN106413736A (zh) 2017-02-15

Similar Documents

Publication Publication Date Title
EP3713931C0 (en) 3-OXO-6-HETEROARYL-2-PHENYL-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDE
DK3253762T3 (da) 9h-pyrrolo-dipyridinderivater.
CL2015000430S1 (es) Alumbrado exterior.
EP3246440A4 (en) Knitted lace
BR112017013156A2 (pt) combinações de composto ativo.
EP3663026A4 (en) Lathe
BR112017018633A2 (pt) tintas brancas.
IT201600084952A1 (it) Coglifrutta.
BR112017012801A2 (pt) combinações de composto ativo.
ES1150114Y (es) Abarcón.
HRP20180585T1 (hr) Spojevi 2,7-diazaspiro[3.5]nonana
ES2789757T8 (es) Herramienta de conformado
LT3253749T (lt) Junginiai, pasižymintys priešnavikiniu aktyvumu
EP3346592A4 (en) Rotating machine
LT3233862T (lt) Imidazopiridazino dariniai, kaip pi3kbeta slopikliai
ITUB20152270A1 (it) Macchina lava-asciuga pavimenti.
CL2015002617S1 (es) Motocicleta.
MX373056B (es) Formas cristalinas de glecaprevir.
BR112016018071A2 (pt) composição de larvicida.
CL2014002529S1 (es) Alumbrado exterior.
MX2020006006A (es) Polimorfos cristalinos de {(2s,3r)-1-[(2s)-2-{5-[(2r,5r)-1-{3,5-di fluoro-4-[4-(4-fluorofenil)piperidin-1-il]fenil}-5-(6-fluoro-2-{( 2s)-1-[n-(metoxicarbonil)-o-metil-l-treonil]pirrolidin-2-il}-1h-b enzimidazol-5-il)pirrolidin-2-il]-6-fluoro-1h-benzimidazol-2-il}p irrolidin-1-il]-3-metoxi-1-oxobutan-2-il}carbamato de metilo.
ITUB20161122A1 (it) Seminatrice.
ITUB20160244A1 (it) Macchina utensile.
ES1124406Y (es) Pieza de hormigón luminiscente.
GB2557192B (en) Semiconductor patterning

Legal Events

Date Code Title Description
FG Grant or registration